Incidence and Outcome of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Cohort of 3165 Patients in Sweden

被引：0
|
作者：
Harrysson, Sara [1 ,2 ]
Eloranta, Sandra [1 ]
Ekberg, Sara [1 ]
Enblad, Gunilla [3 ]
Jerkeman, Mats [4 ]
Hasselblom, Sverker [5 ]
Wahlin, Bjorn E. [2 ,6 ]
Andersson, Per-Ola [7 ,8 ]
Smedby, Karin E. [1 ,2 ]
机构：
[1] Karolinska Inst, Div Clin Epidemiol, Dept Med Solna, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Hematol, Solna, Sweden
[3] Akad Univ Hosp, Dept Oncol, Uppsala, Sweden
[4] Lund Univ, Inst Clin Sci, Dept Oncol & Pathol, Lund, Sweden
[5] Reg Halland, Dept Res Dev & Educ, Halmstad, Sweden
[6] Karolinska Inst, Div Hematol, Dept Med Huddinge, Stockholm, Sweden
[7] South Alvsborg Hosp, Dept Hematol, Boras, Sweden
[8] Gothenburg Univ, Sahlgrenska Acad, Gothenburg, Sweden
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-110672
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2975
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Phylogenetic Evolution in Refractory/Relapsed Diffuse Large B-Cell Lymphoma
    Ruminy, Philippe
    Rainville, Vinciane
    Mareschal, Sylvain
    Etancelin, Pascaline
    Joly, Berangere
    Picquenot, Jean-Michel
    Bastard, Christian
    Tilly, Herve
    Jardin, Fabrice
    BLOOD, 2012, 120 (21)
  • [42] Relapsed or Refractory Diffuse Large B-Cell Lymphoma: "Dazed and Confused"
    Kesireddy, Meghana
    Lunning, Matthew A.
    ONCOLOGY-NEW YORK, 2022, 36 (06): : 360 - 369
  • [43] Polatuzumab vedotin in relapsed/refractory diffuse large B-cell lymphoma
    Dietliker, N.
    Kiesel, H.
    Mueller, R.
    Mueller, A. M.
    Manz, M.
    Zenz, T.
    Rosler, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 66 - 67
  • [44] Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
    Salles, Gilles
    Dlugosz-Danecka, Monika
    Ghesquieres, Herve
    Jurczak, Wojciech
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 455 - 463
  • [45] Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Sehn, Laurie H.
    Herrera, Alex F.
    Flowers, Christopher R.
    Kamdar, Manali K.
    McMillan, Andrew
    Hertzberg, Mark
    Assouline, Sarit
    Kim, Tae Min
    Kim, Won Seog
    Ozcan, Muhit
    Hirata, Jamie
    Penuel, Elicia
    Paulson, Joseph N.
    Cheng, Ji
    Ku, Grace
    Matasar, Matthew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (02) : 155 - +
  • [46] Bendamustine/rituximab in relapsed or refractory diffuse large B-cell lymphoma
    Vacirca, J. L.
    Acs, P. I.
    Shimkus, B. J.
    Rosen, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study
    Ren, Liangliang
    Li, Ling
    Zhang, Lei
    Li, Xin
    Fu, Xiaorui
    Wang, Xinhua
    Wu, Jingjing
    Sun, Zhenchang
    Feng, Xiaoyan
    Chang, Yu
    Zhou, Zhiyuan
    Nan, Feifei
    Yan, Jiaqin
    Kong, Fei
    Zhang, Mingzhi
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2022, 38 (01) : 42 - 50
  • [48] A prognostic nomogram constructed for relapsed or refractory diffuse large B-cell lymphoma patients
    Jiang, Shiyu
    Qin, Yan
    Liu, Peng
    Yang, Jianliang
    Yang, Sheng
    He, Xiaohui
    Zhou, Shengyu
    Gui, Lin
    Zhang, Changgong
    Zhou, Liqiang
    Sun, Yan
    Shi, Yuankai
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (02) : E11 - E16
  • [49] Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study
    Liangliang Ren
    Ling Li
    Lei Zhang
    Xin Li
    Xiaorui Fu
    Xinhua Wang
    Jingjing Wu
    Zhenchang Sun
    Xiaoyan Feng
    Yu Chang
    Zhiyuan Zhou
    Feifei Nan
    Jiaqin Yan
    Fei Kong
    Mingzhi Zhang
    Indian Journal of Hematology and Blood Transfusion, 2022, 38 : 42 - 50
  • [50] DeVIC chemotherapy is effective for patients with refractory or relapsed diffuse large B-cell lymphoma
    Okada, Kazuya
    Sakai, Kazuya
    Muranushi, Hiroyuki
    Okamoto, Yusuke
    Sugiura, Hiroyuki
    Sato, Aki
    Sato, Takayuki
    Maeda, Takeshi
    Onishi, Tatsuhito
    Ueda, Yasunori
    ANNALS OF ONCOLOGY, 2015, 26 : 108 - 108
12345